Skip to main content
EJNMMI Research
Fig. 4 | EJNMMI Research

Fig. 4

From: Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

Fig. 4

In bone metastatic lesions, VEGFR-1 and VEGFR-2 are expressed on non-overlapping subsets of non-endothelial cells. Top panels, Control group. Bottom panels, scVEGF/177Lu treated group. a, d Lack of colocalization between VEGFR-1 and CD31. b, e Lack of colocalization between VEGFR-2 and CD31. c, f Lack of colocalization between VEGFR-1 and VEGFR-2. Nuclei stained with DAPI (blue). ×40 objective

Back to article page